The Australian Government is now in caretaker period. During this time, updates on this website will be published in accordance with the Guidance on Caretaker Conventions, until after the election.
2709 results found
This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2020–21. An accessible version of this document is available on the Transparency Portal.
This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2019–20. An accessible version of this document is available on the Transparency Portal.
This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2021–22. An accessible version of this document is available on the Transparency Portal.
This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2022–23. An accessible version of this document is available on the Transparency Portal.
It is an inspiring time for health and medical research in Australia as the National Health and Medical Research Council (NHMRC) sets the standard for achieving gender equity through its largest grant scheme, Investigator Grants.
Picato® is a prescription gel that treats skin actinic keratosis (potentially pre-cancerous sunspots). The journey to develop this product began in the 1970s when Queensland researcher, Jim Aylward, became interested in a local farming story about the healing properties of the sap of the radium weed Euphorbia peplus (E. peplus) when applied to sunspots on the skin.
MRFF – Preventive and Public Health Research Initiative – 2023 Optimising Screening, Diagnosis and Management of Obstructive Sleep Apnoea Grant Opportunity
NHMRC opened a Targeted Call for Research (TCR) into Frailty in Hospital Care: Complex Health Care on 31 October 2018 and closed on 30 January 2019. Due to an administrative issue at the close of minimum data which disadvantaged some applications, NHMRC elected to reopen this call in the interests of equity and fairness. The re-opened call closed on 21 March 2019.
NHMRC opened a Targeted Call for Research (TCR) into Per- and Poly-Fluoroalkylated Substances (PFAS) on 19 December 2018. Applications closed on 1 May 2019.
NHMRC opened a Targeted Call for Research (TCR) into Biotoxin-related illnesses on 21 July 2021. Applications closed on 15 September 2021.
The information described in the disclosure log table below has been released by NHMRC under the Freedom of Information Act 1982 and is available for public access.
The following tables provide answers to common questions regarding Microbial health-based targets. This information can be found in Chapter 5 of the Australian Drinking Water Guidelines (the Guidelines):
In 2022, working with its Health Research Impact Committee, National Health and Medical Research Council (NHMRC) developed the NHMRC Research Impact Position Statement.